Home
Frontiers Clinical Drug Research - Anti-Cancer Agents: Volume 8
Barnes and Noble
Loading Inventory...
Frontiers Clinical Drug Research - Anti-Cancer Agents: Volume 8 in Franklin, TN
Current price: $95.00
Barnes and Noble
Frontiers Clinical Drug Research - Anti-Cancer Agents: Volume 8 in Franklin, TN
Current price: $95.00
Loading Inventory...
Size: Paperback
Frontiers in Clinical Drug Research - Anti-Cancer Agents
is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
- Key data management elements in clinical trials for oncological therapeutics
- Prospects for therapeutic targeting of microRNAs in brain tumors
- Breast cancer vaccines: current status and future approach
- Desmocollin-3 and cancer
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
- Key data management elements in clinical trials for oncological therapeutics
- Prospects for therapeutic targeting of microRNAs in brain tumors
- Breast cancer vaccines: current status and future approach
- Desmocollin-3 and cancer
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
Frontiers in Clinical Drug Research - Anti-Cancer Agents
is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
- Key data management elements in clinical trials for oncological therapeutics
- Prospects for therapeutic targeting of microRNAs in brain tumors
- Breast cancer vaccines: current status and future approach
- Desmocollin-3 and cancer
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
- Key data management elements in clinical trials for oncological therapeutics
- Prospects for therapeutic targeting of microRNAs in brain tumors
- Breast cancer vaccines: current status and future approach
- Desmocollin-3 and cancer
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
You May Also Like
More About Barnes and Noble at CoolSprings Galleria
Barnes & Noble is the world’s largest retail bookseller and a leading retailer of content, digital media and educational products. Our Nook Digital business offers a lineup of NOOK® tablets and e-Readers and an expansive collection of digital reading content through the NOOK Store®. Barnes & Noble’s mission is to operate the best omni-channel specialty retail business in America, helping both our customers and booksellers reach their aspirations, while being a credit to the communities we serve.
1800 Galleria Blvd #1310, Franklin, TN 37067, United States
